{"id":"50c25960-3f9b-5fb3-b2e5-22975970dcce","stable_key":"d96b230c-481b-535b-930c-04eb87ec7f02:s-allylcysteine-acc","predicate":"increases_tested_phosphorylation_of","statement":"SAC treatment increased ACC phosphorylation in HepG2 cells.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"fe89941e-3694-52e5-98da-0112a3efe08d","mechanism_event_label":"A lipid-synthesis enzyme had a separate measured modification.","subject":{"id":"8c2c295d-68b3-5e62-b1a7-00fcf915e3cc","slug":"s-allylcysteine","display_name":"S-allyl-L-cysteine / SAC","entity_type_key":"small_molecule"},"object":{"id":"f1623f3f-bba0-5289-b1b7-214fb0504a76","slug":"human-acc-assay-family","display_name":"Human acetyl-CoA carboxylase activity, isoform unresolved in assay","entity_type_key":"protein_family"},"evidence_count":1,"mechanism_event":{"id":"fe89941e-3694-52e5-98da-0112a3efe08d","stable_key":"d96b230c-481b-535b-930c-04eb87ec7f02:s-allylcysteine-acc-event","event_type":"observed_relationship","label":"A lipid-synthesis enzyme had a separate measured modification.","description":"SAC treatment increased ACC phosphorylation in HepG2 cells.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8c2c295d-68b3-5e62-b1a7-00fcf915e3cc","slug":"s-allylcysteine","display_name":"S-allyl-L-cysteine / SAC","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"f1623f3f-bba0-5289-b1b7-214fb0504a76","slug":"human-acc-assay-family","display_name":"Human acetyl-CoA carboxylase activity, isoform unresolved in assay","entity_type_key":"protein_family"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"acting_entity","value_text":"s-allylcysteine","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"dose","value_text":"Not specified in accessed abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Not specified in accessed abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_comparison","value_text":"SAC addition; pathway inhibitor comparisons","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Free-fatty-acid-treated HepG2 cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"interpretation_status","value_text":"Source-derived research curation; not independent primary verification","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The accessed abstract does not resolve the ACC isoform or phosphorylation site.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"S-allylcysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"s-allylcysteine","display_name":"S-allyl-L-cysteine / SAC","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A lipid-synthesis enzyme had a separate measured modification.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[23465592] S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23465592/ · DOI 10.1016/j.jnutbio.2012.12.006","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"Cell culture","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Free-fatty-acid-treated HepG2 cells","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"a9f98ab2-9d24-5738-965a-dc98ab05de52","evidence_kind":"source_excerpt","locator":"Lines 194-201","start_line":194,"end_line":201,"excerpt":"## s-allylcysteine-acc\nA lipid-synthesis enzyme had a separate measured modification.\nSAC treatment increased ACC phosphorylation in HepG2 cells.\nModel: Free-fatty-acid-treated HepG2 cells\nLimitations: The accessed abstract does not resolve the ACC isoform or phosphorylation site.\nEvidence access: Primary abstract\n[23465592] S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23465592/ · DOI 10.1016/j.jnutbio.2012.12.006\nStructured context: {\"organism\": \"Homo sapiens\", \"tissue_or_cell_type\": \"Free-fatty-acid-treated HepG2 cells\", \"dose\": \"Not specified in accessed abstract\", \"duration\": \"Not specified in accessed abstract\", \"route\": \"Cell culture\", \"experimental_comparison\": \"SAC addition; pathway inhibitor comparisons\", \"acting_entity\": \"s-allylcysteine\", \"interpretation_status\": \"Source-derived research curation; not independent primary verification\"}","model_system":"Free-fatty-acid-treated HepG2 cells","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"3b0d58f9-8a69-579d-9920-518399a9a8bb","stable_key":"import-d96b230c-481b-535b-930c-04eb87ec7f02","title":"S-allylcysteine: sulfur signaling, redox responses and cross-nutrient mechanisms (2026-09-20)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"91d7aeac82e42ce559d13dd8a2e0165d37760f7f555dd01c80e0604fa6e71ea2","revision_id":"545e497c-e5e3-543c-b26b-b297cbc7bbec","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}